CAPTRUST Financial Advisors
CKPT

CAPTRUST Financial Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-75
Closed -$1K – 2413
2022
Q2 		$1K Hold
75
– – ﹤0.01% 4645
2022
Q1 		$1K Buy
+75
New +$1.61K ﹤0.01% 4665

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

CAPTRUST Financial Advisors's CKPT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Checkpoint Therapeutics (CKPT) in Q3 2022, closing a stake of 75 shares — an estimated $1K sold.

CAPTRUST Financial Advisors first reported a position in CKPT in Q1 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2022. 57 funds tracked by Wall St. Rank hold CKPT as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Checkpoint Therapeutics position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 75 Checkpoint Therapeutics shares in Q3 2022, an estimated $1K.
  • CAPTRUST Financial Advisors first reported a position in Checkpoint Therapeutics in Q1 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Checkpoint Therapeutics position peaked at $1K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.